October 29, 2026

FDA monthly preview: Key November decisions to watch

Upcoming FDA decisions span cancer, cardiovascular disease, rare genetic disorders, and more.

MDSpire News

October 28, 2026

FDA adds generic valganciclovir oral solution

 The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

MDSpire News

October 23, 2026

Lupus nephritis may remit despite HIV

A patient with biopsy-confirmed renal disease achieved remission during immunosuppressive therapy while maintaining stable HIV control.

MDSpire News

October 22, 2026

FDA clears integrated kidney replacement system

The system combines citrate anticoagulation and calcium replacement for critically ill patients receiving continuous kidney replacement therapy.

MDSpire News

October 22, 2026

FDA approves ravulizumab for IgA nephropathy

Phase 3 results showed reduced proteinuria at 34 weeks, but effects on kidney function remain unconfirmed.

MDSpire News

October 22, 2026

Biomaterial approach may help cartilage retain shape

Stem cell–laden constructs maintained curved architecture for 6 days after investigators removed supporting hydrogel framework.

MDSpire News

October 19, 2026

Catheter stop orders may be losing ground

A 20-year national survey reveals substantial gains in infection surveillance but inconsistent use of strategies to limit unnecessary urinary catheterization.

MDSpire News

October 14, 2026

Ureteral obstruction linked to degenerative sacroiliitis

CT identified an unusual cause of hydronephrosis despite stable renal function and no urinary symptoms.

MDSpire News

September 30, 2026

Misleading AI summaries may alter recall

Participants exposed to inaccurate postevent summaries were less likely to correctly remember key details from videos they had previously watched.

MDSpire News

September 28, 2026

FDA expands treatment in nephrotic syndrome

The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.

MDSpire News